Biomarker: F290-IgE Oyster

Overview

Oyster is a mollusk shellfish consumed as food, including the European oyster (Ostrea edulis) used as the F290 allergen source and the Pacific oyster (Crassostrea gigas). Exposure generally occurs through ingestion and, less commonly, occupational or environmental contact with oyster proteins. Oyster proteins can induce IgE sensitization and immediate allergic reactions, including urticaria, gastrointestinal symptoms, respiratory symptoms, or anaphylaxis. Serum-specific IgE testing can help evaluate suspected oyster sensitization, but a positive result indicates sensitization and does not by itself establish clinically confirmed oyster allergy.

Clinical Use Cases

Evaluation of suspected IgE-mediated oyster allergy: Supports investigation when symptoms occur soon after eating oysters or foods containing oyster ingredients.
Serum-specific IgE assessment: Measures IgE antibodies directed against oyster extract in a blood sample as part of an allergy-focused diagnostic evaluation.
Correlation with exposure history: Helps assess whether reported symptoms are consistent with the timing, amount, preparation, and reproducibility of oyster exposure.
Assessment alongside other allergy testing: Results may be interpreted with skin-prick testing, when appropriate, and a medically supervised oral food challenge when the diagnosis remains uncertain.
Evaluation of shellfish sensitization patterns: Testing may be used with other mollusk or crustacean allergens to assess whether sensitization appears species-specific or broadly distributed.
Component-focused investigation: When available, testing for oyster tropomyosin may provide additional information about molecular sensitization, although oyster component testing is not yet as clinically established or widely available as extract-based testing.

Specimen Types

Serum: Commonly used for measurement of oyster-specific IgE.
Blood: Venous blood is collected and processed to obtain serum for laboratory testing.

Measurement Methods

Allergen-specific IgE testing: In-vitro immunoassays measure IgE antibodies binding to oyster extract, reported using laboratory-specific quantitative or class-based results. The F290 source is commonly identified as whole oyster, including Ostrea edulis in established shellfish allergen test systems.
Component-resolved diagnostics: Measures IgE directed against individual allergenic proteins rather than the whole oyster extract. Oyster tropomyosin, designated Cra g 1 in Crassostrea gigas, has been identified as a major allergen in a small human study, but oyster component testing remains less established than extract-based testing.
Skin-prick testing: May provide complementary evidence of sensitization using an appropriate commercial extract or, when clinically justified, fresh oyster material. It is not a blood-based method and should be interpreted with the clinical history.
Oral food challenge: A medically supervised, progressively dosed exposure can confirm or exclude clinical food allergy when the history and sensitization tests do not provide a clear answer. It should not be performed at home.

Test Preparation and Influencing Factors

Fasting: Fasting is generally not required for serum-specific IgE blood testing unless other tests collected at the same time require it.
Medications: Most medications do not prevent collection of a serum-specific IgE sample. Antihistamines can interfere with skin-prick testing but generally do not invalidate serum-specific IgE measurement.
Clinical timing: The timing, reproducibility, and characteristics of symptoms after oyster exposure are essential for interpretation. Symptoms occurring soon after ingestion provide more relevant clinical context than an isolated historical reaction.
Sensitization versus allergy: Detectable oyster-specific IgE demonstrates immunologic sensitization, not necessarily symptomatic allergy. Clinical allergy requires compatible symptoms after exposure and, when needed, confirmation with a supervised oral food challenge.
Cross-reactive sensitization: IgE binding to oyster extract may reflect antibodies directed against conserved proteins shared with other mollusks, crustaceans, house-dust mites, or cockroaches rather than clinically relevant oyster allergy.
Total IgE concentration: A high total IgE concentration and broad atopic sensitization can complicate interpretation of low-level or multiple positive specific-IgE results. Specific-IgE values should therefore be interpreted in clinical context rather than as an isolated threshold.
Allergen extract composition: Whole-food extracts may vary in the representation of individual oyster proteins. This can contribute to differences between extract-based testing and component-focused testing.
Preparation of the oyster: Raw and cooked oysters may expose a person to different amounts or forms of allergenic proteins. The form associated with the reported reaction should be considered during evaluation.
Age and clinical history: Specific-IgE concentrations and the likelihood of persistent food allergy can vary with age and prior exposure history. No single oyster-specific IgE value confirms allergy in every patient.

Cross-Reactivity

Tropomyosin: Oyster tropomyosin is a clinically relevant allergen. In a study of 21 oyster-sensitized patients, IgE from 18 participants recognized Pacific oyster tropomyosin, designated Cra g 1.
Related mollusks: Tropomyosin is conserved among mollusks, including oysters, abalone, snails, squid, and other edible shellfish. IgE binding may therefore occur across these sources, although cross-sensitization does not establish that a person will react clinically to every related food.
Crustaceans: Oyster tropomyosin may share IgE-binding regions with crustacean tropomyosins from shrimp, crab, and lobster. Some individuals may consequently show sensitization to both mollusks and crustaceans, while others may have species-limited clinical reactions.
House-dust mites and cockroaches: Tropomyosin from house-dust mites and cockroaches can contribute to serologic cross-reactivity with shellfish tropomyosin. This may produce positive shellfish-specific IgE results without clinically significant reactions to the shellfish.
Partial cross-sensitization: Human oyster research demonstrates variable IgE binding between oyster, prawn, and dust-mite tropomyosin, consistent with partial cross-sensitization and/or co-sensitization rather than uniform cross-allergy.
Clinical relevance: Cross-reactive IgE can complicate interpretation of F290 results. Testing should be directed by the exposure history, and results should not be interpreted as proof of allergy to all mollusks or crustaceans.